Park and co-workers reported, for instance, the overexpression of NEK4 in lung cancer and suggested that NEK 4 suppresses Tumor necrosis factor-Related Apoptosis Inducing Ligand (TRAIL)-induced apoptosis, which in turn results into tumor resistance. Here, NEK4 is linked to neoplasm.